• DAPI Nuclear Stain Solution: Practical Protocol

  2026-08-17

  DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution provides a ready-to-use fluorescent DNA binding dye for nuclear visualization in fixed or membrane-compromised cells. It supports fluorescence microscopy and flow cytometry workflows for cell viability assessment and apoptosis-related nuclear evaluation, but its weak cell permeability makes it unsuitable as a routine live-cell imaging stain.

• PM2.5, Fra2/LCN2, and Macrophage Ferroptosis

  2026-08-16

  A 2026 Redox Biology study identifies Fra2-driven LCN2 activation as a mechanistic link between PM2.5 exposure, defective mitophagy, and ferroptosis in M2 macrophages during asthma exacerbation. Its combination of multi-omics, promoter-occupancy analysis, cellular ultrastructure, and macrophage-specific in vivo knockdown provides a framework for testing iron-dependent inflammatory mechanisms in environmental asthma.

• ARCA Cy3 EGFP mRNA (5-moUTP) Workflow Guide

  2026-08-15

  Build a two-channel assay that separates mRNA uptake from productive translation. This guide shows how to use a fluorescent, capped, modified reporter to optimize mammalian-cell delivery, compare formulations, and troubleshoot endosomal escape.

• EdU Imaging Kits (HF594) for Treg Proliferation

  2026-08-14

  EdU Imaging Kits (HF594) combine S-phase labeling with red-fluorescent click chemistry for sensitive cell proliferation measurements in microscopy and flow cytometry. The workflow is especially useful for separating Treg expansion from differentiation-marker changes in asthma and immunology studies.

• Verteporfin Activates IRE1α to Sensitize Breast Cancer

  2026-08-14

  A 2025 Cell Chemical Biology study identifies verteporfin as a molecular glue-like activator of IRE1α, promoting His692-dependent dimerization, XBP1 splicing, and downstream regulation of PTEN, AKT, and BACH1. The work provides a mechanistic rationale for combining verteporfin with AKT inhibition to suppress breast cancer growth and invasion more effectively than either strategy alone.

• DAF-2 diacetate for NO Imaging in Nodules

  2026-08-13

  DAF-2 diacetate converts intracellular nitric oxide activity into a retained fluorescent signal, supporting live-cell imaging, biochemical assays, and plant nodule research. This workflow connects sensitive NO measurements with the sulfur-dependent control of soybean nodule senescence described in recent Nature Communications research.

• IR-1061: Near Infrared Fluorescent Dye Workflows

  2026-08-13

  IR-1061 supports low-background NIR-II imaging when the dye is freshly prepared and correctly formulated. This guide translates carrier selection, loading control, and assay troubleshooting into practical workflows for deep-tissue, vascular, and other biomedical imaging studies.

• EdU Imaging Kits (Cy3) in Cholangiocarcinoma Research

  2026-08-12

  EdU Imaging Kits (Cy3) convert a short DNA-replication pulse into a bright, quantifiable readout for cholangiocarcinoma cell proliferation. This guide connects the assay to senescence-related biomarker research, drug-response testing, fluorescence imaging, and practical workflow troubleshooting.

• FerroOrange: Live-Cell Fe²⁺ Detection Workflow

  2026-08-12

  FerroOrange converts intracellular Fe²⁺ activity into a fluorescence readout that can be integrated with microscopy, flow cytometry, or plate-based screening. This practical guide connects live-cell assay design with the Cdk5–AMPK–ferroptosis findings reported in ischemic-stroke models, while emphasizing controls, optimization, and interpretation limits.

• BCECF and the Translational Logic of Tissue Acidity

  2026-08-11

  Extracellular acidity is often treated as a background variable, yet it can reshape transporter activity, metabolism, immune-cell behavior, and disease-model interpretation. This thought-leadership article positions BCECF as a practical bridge between mechanistic signaling studies and quantitative microenvironmental pH analysis, using recent neuropathic pain research to define opportunities, limitations, and a translational validation strategy.

• Resazurin Sodium Salt for Cell Viability

  2026-08-11

  Resazurin sodium salt is a fluorogenic oxidation-reduction indicator that converts cellular reducing activity into a resorufin fluorescence signal. Its DMSO solubility, red-fluorescent readout, and compatibility with scalable formats support viability, proliferation, and cytotoxicity workflows when exposure time and concentration are controlled.

• Glutamine Metabolism in HSCs and Liver Fibrosis

  2026-08-10

  The reference study identifies a SIRT4–GDH metabolic axis that sustains glutamine catabolism, energy production, and hepatic stellate cell activation during liver fibrosis. Its combination of pharmacological and genetic evidence suggests that restraining glutamate conversion to α-ketoglutarate may reduce HSC proliferation and fibrosis progression, while also highlighting important limits for translation.

• Ciclesonide: Mechanism and Research Uses

  2026-08-09

  Ciclesonide is a glucocorticoid receptor agonist prodrug that is converted in lung cells to the more potent metabolite desisobutyryl-ciclesonide. Its localized activation, receptor pharmacology, and anti-inflammatory benchmarks support asthma treatment research and allergic rhinitis treatment studies, while its evidence does not establish a role in ERAD-based protein degradation.

• Hoechst 33342 for Fibroblast Senescence Assays

  2026-08-08

  Discover how Hoechst 33342 can serve as more than a nuclear label in dermal fibroblast senescence research. This guide connects live-cell imaging, fixed-cell analysis, and flow cytometry with mitochondrial quality-control readouts inspired by recent pterostilbene research.

• Galectin-1, FIP200, and Hepatic Steatosis

  2026-08-07

  The reference study identifies galectin-1 as an upstream inhibitor of hepatic autophagy that promotes steatosis, dyslipidemia, and insulin resistance through direct interaction with FIP200. Its combination of in vivo metabolic phenotyping, proteomic analysis, binding studies, and interaction-disrupting mutations provides a mechanistic framework for studying the Gal-1–FIP200 axis in NAFLD.

541 records 7/37 page Previous Next First page 上5页 678910 下5页 Last page